Indication
Cervical Intraepithelial Neoplasia Grade 2
1 clinical trial
1 product
1 drug
Clinical trial
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase IIc Clinical Trial of ALA-PDT in Patients With Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in p16-positivity and High-risk HPV InfectionStatus: Completed, Estimated PCD: 2023-12-20
Product
Aminolaevulinic acidDrug
Varlilumab